Epidemiological and therapeutic studies on gonococcal infections--one shot therapy by spectinomycin--[Sapporo Clinical Research Group for STD

From January through March of 1985, the Sapporo Clinical Research Group for STD treated 69 cases of gonococcal infections (61 cases of male gonococcal urethritis and 8 cases of female gonococcal cervicitis) at its facilities in Sapporo City. The therapeutic efficacy of one shot therapy of Spectinomy...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 33(1987), 1 vom: 01. Jan., Seite 157-68
1. Verfasser: Sakai, S (VerfasserIn)
Weitere Verfasser: Kumamoto, Y, Tsunekawa, T, Hirose, T, Tabata, S, Goro, T, Inoke, T, Igawa, K, Henmi, I, Tanda, H
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1987
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Spectinomycin 93AKI1U6QF
LEADER 01000caa a22002652c 4500
001 NLM029345170
003 DE-627
005 20250126092718.0
007 tu
008 231221s1987 xx ||||| 00| ||jpn c
028 5 2 |a pubmed25n0098.xml 
035 |a (DE-627)NLM029345170 
035 |a (NLM)2953180 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Sakai, S  |e verfasserin  |4 aut 
245 1 0 |a Epidemiological and therapeutic studies on gonococcal infections--one shot therapy by spectinomycin--[Sapporo Clinical Research Group for STD 
264 1 |c 1987 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 08.06.1987 
500 |a Date Revised 09.12.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a From January through March of 1985, the Sapporo Clinical Research Group for STD treated 69 cases of gonococcal infections (61 cases of male gonococcal urethritis and 8 cases of female gonococcal cervicitis) at its facilities in Sapporo City. The therapeutic efficacy of one shot therapy of Spectinomycin (SPCM) was investigated, and an epidemiological study on the cases and bacteriological studies on the isolated strains of Neisseria gonorrhoeae were made. The male patients were between 19 and 55 years old, with a peak age distribution in the younger half of the twenties. The female patients were between 18 and 40 years old. The major source of infections was a so-called special massage parlor which accounted for 36.1% of male cases. The isolation rate of PPNG were 16.7% (11/66). The MIC (inoculum size; 10(6) CFU/ml) of SPCM ranged from 3.13 to 25 micrograms/ml regardless of beta-lactamase production. In male patients, the eradication rate (efficacy rate) of N. gonorrhoeae by SPCM was 94.7% on the first day, 93.6% on the third day and 100% on the seventh day after 2 g one shot therapy. In female patients, the rate was 100% on the third and seventh day after 2 g one shot therapy, and 75% on the first day, 66.7% on third day and 100% on seventh day after 4 g one shot therapy. We considered that one shot therapy of SPCM was effective for gonococcal infection also in the present time. Especially SPCM was effective for infections by PPNG, since it was not resolved by beta-lactamase of N. gonorrhoeae. Positive rate of Chlamydia trachomatis was 16.3% in male gonococcal urethritis, and the serous discharge tended to remain longer in the positive patients than in the negative patients. There was only one side effect (1.4%), therefore SPCM was recognized to be a safely administrated antimicrobial agent 
650 4 |a Journal Article 
650 7 |a Spectinomycin  |2 NLM 
650 7 |a 93AKI1U6QF  |2 NLM 
700 1 |a Kumamoto, Y  |e verfasserin  |4 aut 
700 1 |a Tsunekawa, T  |e verfasserin  |4 aut 
700 1 |a Hirose, T  |e verfasserin  |4 aut 
700 1 |a Tabata, S  |e verfasserin  |4 aut 
700 1 |a Goro, T  |e verfasserin  |4 aut 
700 1 |a Inoke, T  |e verfasserin  |4 aut 
700 1 |a Igawa, K  |e verfasserin  |4 aut 
700 1 |a Henmi, I  |e verfasserin  |4 aut 
700 1 |a Tanda, H  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 33(1987), 1 vom: 01. Jan., Seite 157-68  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnas 
773 1 8 |g volume:33  |g year:1987  |g number:1  |g day:01  |g month:01  |g pages:157-68 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 33  |j 1987  |e 1  |b 01  |c 01  |h 157-68